Treatment of Severe Acute Respiratory Syndrome With Glucosteroids

Drosten, 2003, Identification of a novel coronavirus in patients with severe acute respiratory syndrome, N Engl J Med, 348, 1967, 10.1056/NEJMoa030747 Hui, 2004, Treatment of severe acute respiratory syndrome, Chest, 126, 670, 10.1378/chest.126.3.670 Zhao, 2003, Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China, J Med Microbiol, 52(Pt 8), 715, 10.1099/jmm.0.05320-0 So, 2003, Development of a standard treatment protocol for severe acute respiratory syndrome, Lancet, 361, 1615, 10.1016/S0140-6736(03)13265-5 Ho, 2003, High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome, Am J Respir Crit Care Med, 168, 1449, 10.1164/rccm.200306-766OC Meng, 2003, Use of glucocorticoid in treatment of severe acute respiratory syndrome cases, Zhonghua Yu Fang Yi Xue Za Zhi, 37, 233 Xiao, 2004, Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy, Chin J Intern Med, 43, 179 Sung, 2004, Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak, Thorax, 59, 414, 10.1136/thx.2003.014076 Zhong, 2004, Management and prevention of SARS in China, Phil Trans R Soc Lond B Biol Sci, 359, 1115, 10.1098/rstb.2004.1491 Cheng, 2004, Medical treatment of viral pneumonia including SARS in immunocompetent adult, J Infect, 49, 262, 10.1016/j.jinf.2004.07.010 Tsang, 2003, SARS: pharmacotherapy, Respirology, 8, 25, 10.1046/j.1440-1843.2003.00525.x Mishra, 2004, High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome, Can Respir J, 11, 311, 10.1155/2004/364284 Lee, 2003, A major outbreak of severe acute respiratory syndrome in Hong Kong, N Engl J Med, 348, 1986, 10.1056/NEJMoa030685 Wu, 1984, 54 Zheng, 2003, The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome, Chin J Respir Crit Care Med, 2, 270 Hong, 1996, Nosocomial infections and nosocomial pneumonia, Am J Surg, 172, 33S, 10.1016/S0002-9610(96)00348-0 2003, Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS), Natl Med J China, 83, 1731 Tian, 2004, Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test, Natl Med J China, 84, 642 Gao, 2003, A preliminary study of serum antibody level in SARS patients, Chin J Virol, 19, 203 Chen, 2003, Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment, Chin J Emerg Med, 12, 366 Zhong, 2003, Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003, Lancet, 362, 1353, 10.1016/S0140-6736(03)14630-2 Li, 2003, Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report, Chin J Intern Med, 42, 378 Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006 Tsang, 2003, Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality, Emerg Infect Dis, 9, 1381, 10.3201/eid0911.030400 Modig, 1985, High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia, Acta Chir Scand, (Suppl)526, 94 Luce, 1988, Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock, Am Rev Respir Dis, 138, 62, 10.1164/ajrccm/138.1.62 Bernard, 1987, High dose corticosteroids in patients with the adult respiratory distress syndrome, N Engl J Med, 31, 1565, 10.1056/NEJM198712173172504 Meduri, 2002, Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome, Am J Respir Crit Care Med, 165, 983, 10.1164/ajrccm.165.7.2106014 Shinozaki, 2004, Respiratory and cadiovascular management of septic ALI-ARDS and shock, Nippon Rinsho, 62, 2301 Meduri, 1995, Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 β and IL-6 levels are consistent and efficient predictors of outcome over time, Chest, 107, 1062, 10.1378/chest.107.4.1062 Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5 Jiang, 2005, Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome, Am J Respir Crit Care Med, 171, 850, 10.1164/rccm.200407-857OC Wong, 2004, Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome, Clin Exp Immunol, 136, 95, 10.1111/j.1365-2249.2004.02415.x Jones, 2004, Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids, Clin Exp Immunol, 135, 467, 10.1111/j.1365-2249.2003.02391.x Shen, 2004, Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou, Natl Med J China, 84, 1814 Griffith, 2005, Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids, Radiology, 235, 168, 10.1148/radiol.2351040100 Li, 2004, Factors of avascular necrosis of femoral head and osteoporosis in SARS patients’ convalescence, Natl Med J China, 84, 1348 Hong, 2004, Avascular necrosis of bone in severe acute respiratory syndrome, Clin Radiol, 59, 602, 10.1016/j.crad.2003.12.008